Human iPS cell–derived respiratory organoids as a model for respiratory syncytial virus infection
Life Science Alliance · 2025-07 · 8 (7) · e202402837
DOI: 10.26508/lsa.202402837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 22.04.2025. Verfasst von Rina Hashimoto und 15 weiteren Autor:innen. Beteiligte Einrichtung: Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Organoids, Respiratory Syncytial Virus Infections, Induced Pluripotent Stem Cells, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, MEXT | Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Respiratory syncytial virus (RSV) is a seasonal respiratory pathogen that primarily affects young children, potentially causing severe lower respiratory tract disease. Despite the high disease burden, understanding of RSV pathophysiology remains limited. To address this, advanced RSV infection models are needed. Whereas HEp-2 cells are widely used because of their high susceptibility to RSV, they do not accurately reflect the host response of the human respiratory tract. In this study, we evaluated human-induced pluripotent stem cell-derived respiratory organoids, which contain respiratory epithelial cells, immune cells, fibroblasts, and vascular endothelial cells, for their potential to model RSV infection and support pharmaceutical research. RSV-infected organoids exhibited high viral genome and protein expression, epithelial layer destruction, and increased collagen accumulation. Pro-inflammatory cytokine levels in culture supernatants also increased post-infection. Furthermore, RSV infection was significantly inhibited by monoclonal antibodies (nirsevimab, palivizumab, suptavumab, or clesrovimab), although ribavirin showed limited efficacy. These findings highlight the utility of respiratory organoids for RSV research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
- Department of Synthetic Human Body System, Medical Research Institute, Institute of Integrated Research, Institute of Science Tokyo, Tokyo, Japan.
- Department of Viral Pathogenesis and Controls, National Center for Global Health and Medicine, Ichikawa, Japan.
- Department of Microbiology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
- Laboratory of Ultrastructural Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
- CREST, Japan Science and Technology Agency, Saitama, Japan.
ORCID-Profile: Abeer Keshta, Yasufumi Matsumura, Takuya Yamamoto, Miki Nagao, Kazuo Takayama
Förderung
- Japan Agency for Medical Research and Development
- MEXT | Japan Society for the Promotion of Science
Zitieren
APA
Hashimoto, R., Watanabe, Y., Keshta, A., Sugiyama, M., Kitai, Y., Hirabayashi, A., Yasuhara, N., Morimoto, S., Sakamoto, A., Matsumura, Y., Nishimura, H., Noda, T., Yamamoto, T., Nagao, M., Takeda, M., & Takayama, K. (2025). Human iPS cell–derived respiratory organoids as a model for respiratory syncytial virus infection. Life Science Alliance, 8(7), e202402837. https://doi.org/10.26508/lsa.202402837
Vancouver
Hashimoto R, Watanabe Y, Keshta A, Sugiyama M, Kitai Y, Hirabayashi A, et al. Human iPS cell–derived respiratory organoids as a model for respiratory syncytial virus infection. Life Science Alliance. 2025;8(7):e202402837. doi:10.26508/lsa.202402837
BibTeX
@article{Hashimoto2025,
author = {Hashimoto, Rina and Watanabe, Yukio and Keshta, Abeer and Sugiyama, Masaya and Kitai, Yuki and Hirabayashi, Ai and Yasuhara, Naoko and Morimoto, Shiho and Sakamoto, Ayaka and Matsumura, Yasufumi and Nishimura, Hidekazu and Noda, Takeshi and Yamamoto, Takuya and Nagao, Miki and Takeda, Makoto and Takayama, Kazuo},
title = {Human iPS cell–derived respiratory organoids as a model for respiratory syncytial virus infection},
journal = {Life Science Alliance},
year = {2025},
volume = {8},
number = {7},
pages = {e202402837},
doi = {10.26508/lsa.202402837}
}
EUVIMED